Venture Capital

Volcanics Venture

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Seed, Early Stage, Growth, Late Stage

Geographical Focus
China

Industries Focus

  • Technology
  • Healthcare

Investment Size:
1,000,000 to 50,000,000 USD

Investor Details Founded: 2016

Volcanics Venture is a venture capital firm based in Shanghai, China, focusing on early-stage investments in technology and healthcare sectors. The firm identifies and supports high-growth potential startups in these industries, aiming to provide sustainable value-added services to its portfolio companies and superior returns to its limited partners.

Established in May 2016, Volcanics Venture is managed by founding partners Suyang Zhang, Yeshun Dong, and Ying Wu, who collectively bring over 60 years of experience in venture capital investment and corporate management. Their expertise enables the firm to effectively navigate the dynamic Chinese market and foster the growth of innovative companies.

The firm's investment strategy encompasses a broad spectrum of stages, including seed, early, growth, and late stages, with investment sizes ranging from $1 million to $50 million. This approach allows Volcanics Venture to cater to a diverse array of companies, from nascent startups to more established enterprises seeking expansion capital.

Volcanics Venture has a proven track record of successful investments in various sectors, demonstrating its commitment to fostering innovation and supporting the growth of promising companies in China.

Requirements
  • High growth potential
  • Innovative technology
  • Strong management team
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Triastek
  • Alluxio
  • Zenlayer
  • Geek+
  • RootPath Genomics
  • Oncologie
Claim this Investor

Are you an official representative of Volcanics Venture?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim